Companies: 10,795·Total market cap: $144.5T
Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.

COLLNASDAQHealthcare● Active
$33.27
$-0.11(-0.33%)
Market Cap$1.1B
P/E Ratio
52W High$50.787
52W Low$29.08
Overview

Collegium Pharmaceutical, Inc. (COLL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · COLL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$2.37coll eps ttm · coll earnings per shareEarnings history
PE Ratio (TTM)14.0×coll pe ratio ttm · coll price to earningsPE Ratio deep dive
Revenue (TTM)$796.3Mcoll revenue ttm · coll annual revenueFull revenue history
Dividend YieldNo Dividenddoes coll pay dividends · coll dividend yieldDividend history
Shares Outstanding31.7Mcoll shares outstanding · coll floatShares outstanding history
Next EarningsAug 6, 2026Est.coll earnings date · coll next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$780.6M▲ +23.62% YoY
202320242025
collegium pharmaceutical, inc. revenue · coll revenue 2025
FY 2025Net Income$62.9M▼ 9.13% YoY
202320242025
collegium pharmaceutical, inc. net income · coll profit 2025
FY 2025EPS$1.98▼ 7.48% YoY
202320242025
coll eps · collegium pharmaceutical, inc. earnings per share 2025
TTM:Revenue: $796.3MNet Income: $74.9MEPS: $2.37View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy12 analystsis coll a buy · coll analyst rating
Strong Buy
0
Buy
8
Hold
3
Sell
1
Strong Sell
0
12-Month Price Target
$56.00Low
$33.27Current
$58.00Avg Target74.33% upside
$60.00High
coll price target · coll 12 month forecast

Total: 12 · Buy rate: 66.7%

The COLL analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $58.00, representing +74.33% upside from the current price of $33.27.

Stock Performance

Full History
1D-0.37%
1W+9.11%
1M-12.02%
3M-10.82%
YTD-28.17%
1Y+9.25%
5Y+47.87%

About Collegium Pharmaceutical, Inc.

CEOVikram Karnani
IPO DateMay 7, 2015
Employees357
CountryUS

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significan…

what is collegium pharmaceutical, inc. · coll stock overview · collegium pharmaceutical, inc. company profile · who is collegium pharmaceutical, inc. ceo · coll NASDAQ · collegium pharmaceutical, inc. headquarters · collegium pharmaceutical, inc. business segments

About Stock Overview & Key Data

Collegium Pharmaceutical, Inc. (COLL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 7, 2015. As of the latest trading session, COLL stock price is $33.27, with a market capitalization of $1.1B. The stock has returned +9.25% over the past 12 months and -28.17% year-to-date.

According to 12 Wall Street analysts, the consensus rating for Collegium Pharmaceutical, Inc. stock is Buy, with an average 12-month price target of $58.00. In fiscal year 2025, Collegium Pharmaceutical, Inc. reported revenue of $780.6M and net income of $62.9M. For detailed data — including Collegium Pharmaceutical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Collegium Pharmaceutical, Inc. (COLL) stock price is $33.27. The stock is traded on NASDAQ under the ticker symbol COLL. The 52-week range is $29.08 – $50.79.

COLL stock priceCOLL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice